4//SEC Filing
Eleven Biotherapeutics, Inc. 4
Accession 0001485003-16-000113
$CARMCIK 0001485003operating
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:19 PM ET
Size
5.6 KB
Accession
0001485003-16-000113
Insider Transaction Report
Form 4
Tubridy Karen L
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-06-15+13,344→ 13,344 totalExercise: $0.28From: 2016-06-15Exp: 2026-02-24→ Common Stock (13,344 underlying)
Footnotes (1)
- [F1]On February 25, 2016, the reporting person was granted an option to purchase 40,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 13,344 shares.
Documents
Issuer
Eleven Biotherapeutics, Inc.
CIK 0001485003
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001485003
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:19 PM ET
- Size
- 5.6 KB